| |
|
| |
|
| |
NeuroResearch Clinics, Inc. |
| |
AMA Category 1
|
| |
Continuing Medical Education |
|
|
|
|
|
|
|
|
|
TREATMENT PROTOCOLS |
|
Written by:
Marty Hinz,
MD |
|
President
Clinical
Research |
|
NeuroResearch
Clinics,
Inc. |
|
|
|
THE POWER IN
OUR HANDS |
|
|
The precursor of
serotonin is 5-HTP aka 5HTP or 5 HTP. The
precursors of dopamine tyrosine
aka L-tyrosine, and L-dopa aka dopa. Taking these precursors is
so safe that they are available in
the United States over the counter
without a prescription. A unique
chemical property of 5-HTP aka 5HTP
or 5 HTP
and L-dopa aka dopa is that they are
synthesized by the body to serotonin
and dopamine neurotransmitter
molecules without biochemical
feed back regulation. There
virtually no inhibition of serotonin
and dopamine
synthesis meaning the more 5-HTP aka
5HTP or 5 HTP and L-dopa aka dopa you give the more
serotonin and dopamine you get in
you system. Based on our work
testing urinary serotonin and
dopamine neurotransmitter levels we know that 5-HTP
aka 5HTP or 5 HTP
and L-dopa aka dopa has the
ability to establish serotonin and
dopamine levels in the body far
higher than is needed to relieve
symptoms of any of disease
such as depression, ADHD, etc.
|
|
Common thinking in medicine is serotonin and/or
dopamine neurotransmitter levels
that are low cause disease such as
depression, ADHD, etc. Yet here in
the hands of every American is the
very things needed to establish
serotonin and dopamine
neurotransmitter levels as
high as we want 5-HTP aka 5HTP or 5
HTP and
L-dopa aka dopa. Prior to the start
of this
research project in 1997 there were no formal studies showing
5-HTP aka 5HTP or 5 HTP and L-dopa
aka dopa were truly effective in
treatment of disease
such as depression, ADHD, etc. To the
contrary all previous studies have
not shown effectiveness of 5-HTP aka
5HTP or 5 HTP and L-dopa aka dopa or were
inconclusive at best. The question
then is, "Why have
5-HTP aka 5HTP or 5 HTP and L-dopa
aka dopa never been
formally proven effective in the
treatment of depression,
ADHD, and
a number of other diseases
in scientific studies?" The
answer is that dosing needs
of 5-HTP aka 5HTP or 5 HTP and L-dopa
aka dopa
to be individualized, 5-HTP
aka 5HTP or 5 HTP and L-dopa aka
dopa needs to
be used in proper balance
and 5-HTP aka 5HTP or 5 HTP and L-dopa
aka dopa
needs to be used in proper
amounts at which point 5-HTP
aka 5HTP or 5 HTP and L-dopa aka
dopa work very
well." |
|
PROTOCOL
OVERVIEW |
|
The natural protocols of
NeuroResearch using 5-HTP aka 5HTP
or 5 HTP ,
tyrosine aka L-tyrosine, and L-dopa
aka dopa are highly effective in
getting patients off
serotonin and dopamine neurotransmitter
depression and ADHD drugs that work
with serotonin and dopamine. 5-HTP
aka 5HTP or 5 HTP , tyrosine aka
L-tyrosine, and
L-dopa aka dopa are effective keeping
drugs working especially in weight
loss, depression, ADHD, and all other
diseases where drugs that work with
serotonin and dopamine are
prescribed. 5-HTP aka 5HTP or 5 HTP , tyrosine
aka L-tyrosine, and L-dopa aka dopa
excels as an alternative treatment
to prescription drugs that work with
serotonin and catecholamines
(dopamine, norepinephrine, and
epinephrine). Unlike depression and
ADHD prescription
drugs that do nothing to increase
neurotransmitter levels of serotonin
and dopamine in the brain and
actually deplete the
neurotransmitter levels of serotonin
and dopamine in most patients, the
NeuroResearch using balanced 5-HTP
aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa
aka dopa increases the neurotransmitter levels
of serotonin and dopamine in the
brain to the point where relief of
symptoms is experienced.
|
|
|
|
These 5-HTP aka 5HTP or 5 HTP , tyrosine
aka L-tyrosine, and L-dopa aka dopa protocols are highly effective
but only in the hands of those that
know how to use the 5-HTP aka 5HTP
or 5 HTP ,
tyrosine aka L-tyrosine, and L-dopa
aka dopa. If the
established 5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine,
and L-dopa aka dopa protocols are followed
we have seen 100% relief of
depression, fibromyalgia, ADHD,
migraine headaches, anxiety, panic
attacks, obsessive compulsive
disorder, phobias, and other
diseases.
symptoms.
|
|
Taking the 5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and
L-dopa aka dopa is not
like taking an aspirin where
you take a pill and feel
better in one half hour. It
takes 3 to 5 days once the
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and
L-dopa aka dopa are started for maximum
results to be seen. In patients that
has experienced relief of
depression, ADHD, etc. symptoms
and the symptoms return it might be
from missing one or more doses of
pills. From the patient's
perspective it appears that the
pills have quit working when the
real problem is missing pills.
|
|
|
|
These results are only obtained by
following the 5-HTP aka 5HTP or 5
HTP ,
tyrosine aka L-tyrosine,
and L-dopa aka dopa protocols. If the
dosing of 5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa
aka dopa is not adjusted
properly or if urinary
serotonin and dopamine neurotransmitter testing is not
obtained when indicated the patient
may be left in a state with no
relief of symptoms and only a bunch
of medical bills to show for it.
|
|
Tyrosine aka L-tyrosine and
L-dopa aka dopa deplete
the sulfur amino
acids when this happens
glutathione and a host of
other things are depleted or
not synthesized properly. A
sulfur amino acid must be
given in proper amounts when
using tyrosine aka
L-tyrosine and/or
L-dopa aka dopa. The top link to the
right notes loss of "total
glutathione" in Parkinson
patients treated with
L-dopa aka dopa. We have chosen the
sulfur amino acid cysteine
which is the least expensive
of all the sulfur amino
acids. Daily dosing of the
chosen sulfur amino acid
needs to be 4,500 mg per
day, This dosing
recommendation was arrived
at through objective
observation with data base
analysis. |
|
|
PAST
STUDIES
OF 5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine AND L-dopa
aka dopa |
|
|
|
Using the urinary
serotonin and the dopamine
neurotransmitter
approach invented by
NeuroResearch
Clinics, Inc. in
2001 we now know the
reason 5-HTP aka
5HTP or 5 HTP,
tyrosine
aka L-tyrosine and L-dopa aka dopa
has not proven
effective in
previous formal
studies relates
primary to flaws in
the design of these
serotonin and
dopamine studies. |
|
First, in looking at the dosing needs of
5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa
aka dopa in a large
group of patients the individual
dosing needs vary on a huge scale
with some patients needing very high
or very low dose of 5-HTP aka 5HTP
or 5 HTP or
L-dopa aka dopa in conjunction with
very high or very low dose of the
other simultaneously. Most of the previous studies
simply gave a specific dose of one
precursor of 5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine,
and L-dopa aka dopa and looked for results. |
|
The second consideration is that
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and
L-dopa aka dopa
need to be in balance with each
other for proper results. This
fact takes on many
considerations. In working with
5-HTP aka 5HTP or 5 HTP and L-dopa
aka dopa more is not always
better, too much of one or too little of the other
can lead to no relief of symptoms.
The balance of 5-HTP aka 5HTP or 5
HTP,
tyrosine aka L-tyrosine, and L-dopa
aka dopa has to be just right to
get the serotonin and dopamine neurotransmitter levels just right. |
|
|
N-Acetyl-tyrosine aka
L-tyrosine
IS NOT |
|
AN
EFFECTIVE PRECURSOR OF
DOPAMINE |
|
|
|
N-acetyl-tyrosine
aka L-tyrosine (NAT)
is synthesized from tyrosine
aka L-tyrosine. The
equilibrium of the chemical reaction
lies far toward NAT, meaning very little
NAT is converted to tyrosine
aka L-tyrosine (the
reaction that is needed if NAT is to
serve as a precursor of L-dopa aka dopa). This
fact has been known in medicine for
years. The practical knowledge comes
from the study of kidney
dialysis patients who need
tyrosine aka
L-tyrosine replacement after
dialysis. In kidney dialysis
when N-acetyl-tyrosine
aka L-tyrosine is administered, there
are no significant increase
in tyrosine aka L-tyrosine levels detected. |
|
PHENYLALANINE NOT OPTIMAL |
|
Phenylalanine is the
precursor of tyrosine
aka L-tyrosine, as
such it is a better
precursor than NAT. The
problem with phenylalanine
is it is too far up the
chemical pathway to be a
predictable precursor for
neurotransmitter synthesis.
It is shuttled to other
pathways and does not
provide predictable clinical
results. For those that
attempt to use phenylalanine
or N-acetyl-tyrosine
aka L-tyrosine as a
dopamine precursor the
question is, "Why?" When the
effective precursors
5-HTP
aka 5HTP or 5 HTP, tyrosine aka
L-tyrosine, and L-dopa aka dopa
are readily available. |
| |
|
|
|
|
|
| |
|
|
| |
|
5-HTP aka 5HTP or 5
HTP, tyrosine
aka L-tyrosine, AND L-dopa aka dopa DEPLETE DOPAMINE AND SEROTONIN IF NOT
GIVEN IN PROPER BALANCE |
|
Based on the
research of NeuroResearch Clinics we realized in 1999 that using only
5-HTP aka 5HTP or 5 HTP depletes dopamine, and using only
L-dopa aka dopa depletes serotonin.
So what does this look like from a clinical stand point when serotonin or
dopamine become depleted? If serotonin or dopamine becomes too low the
effects of L-dopa aka dopa or 5-HTP aka 5HTP or 5 HTP respectively will no longer be seen (they
quit working). |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
| |
|
|
| 5HTP_1 |
 |
|
|
|
APPROACHES TO THERAPY WITH 5-HTP
aka 5HTP or 5 HTP, TYROSINE aka L-tyrosine,
AND L-DOPA aka dopa |
|
|
 |
|
|
|
|
|
|
 |
| |
| |
| |
| |
| |
| 5HTP_3 |
 |
|
|
|
With regards to dosing of
5-HTP aka 5HTP or 5 HTP tyrosine aka
L-tyrosine AND L-dopa aka dopa: |
|
ONE SIZE DOES NOT FIT ALL |
| |
|
Simply placing
patients on a fixed dosing of 5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine, or L-dopa aka dopa for many weeks without
relief of symptoms is a waste of money and causes
patients to needlessly suffer, patients need to have
weekly adjustments of
5-HTP aka 5HTP or 5 HTP, tyrosine aka L-tyrosine, or L-dopa
aka dopa until symptoms are
under control. |
| |
|
Individualized dosing of 5-HTP aka 5HTP or 5
HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa needs to be established
for each patient in order for proper electrical firing
of the serotonin and dopamine neurons to be established. This in turn will lead
to relief of symptoms. |
|
|
|
|
All too
often we see care givers who continue the same dose of
5-HTP aka 5HTP or 5 HTP, tyrosine aka L-tyrosine, or L-dopa
aka dopa after one week of treatment in cases where
there is no relief of symptoms disease such as
depression, ADHD, etc. Continuing patients on a
dosing level of
5-HTP
aka 5HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa
aka dopa
that does
not give relief of symptoms in one week will not provide relief of symptoms
with further time. |
|
|
|
Not
ordering serotonin and dopamine urinary neurotransmitter
testing for patients not responding to
treatment on the level 3 5-HTP aka 5HTP
or 5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka
dopa dosing
fails to offer patients the benefits
that urinary serotonin and dopamine neurotransmitter testing has to offer.
This leaves many patients, who should be
symptom free by taking 5-HTP aka 5HTP or
5 HTP,
tyrosine aka L-tyrosine, or L-dopa aka
dopa with symptoms. |
|
|
|
Therapy with
5-HTP aka 5HTP or 5 HTP, tyrosine aka
L-tyrosine, and
L-dopa aka dopa is
optimally effective only when each
individual patient’s dosing needs is
established.
In
patients that are not properly
responding to adjustments in the 5-HTP
aka 5HTP or 5 HTP, tyrosine aka
L-tyrosine, and
L-dopa aka dopa dosing
this involves proper
adjustment of 5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine,
and L-dopa aka dopa doses and
ordering laboratory urinary
serotonin and dopamine neurotransmitter testing when indicated. |
|
|
|
|
|
SEE YOUR PATIENTS
WEEKLY |
|
There
are occasional patients who report complete relief of symptoms
of disease such as depression, ADHD, etc.
within hours of starting
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa. Many patients
with depression, ADHD, etc. obtain relief of symptoms in the first week or two (on
the level 1 or level 2 dosing of
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa).
|
|
On the
other end of the spectrum are those patients who need 4
to 6 urinary serotonin and dopamine neurotransmitter tests to obtain relief of symptoms
(after no relief of symptoms on level 3
5-HTP
aka 5HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa
aka dopa dosing
for one week). It is
critical to see patients weekly since it will take
2 to 3 months for relief of symptoms of disease such as
depression, ADHD, etc. in the most
difficult cases. If you see these
patients every 2 to 4 weeks while adjusting
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa,
it may take 6 to 8 months for relief of symptoms of
depression, ADHD, etc. to be
obtained in some patients. Most patients with
depression, ADHD, etc. will drop out of treatment
before that happens. |
|
|
|
ORDERING TESTING
WHEN INDICATED |
|
While
urinary serotonin and dopamine neurotransmitter testing can be ordered by the
care giver at any point in treatment, baseline urinary
serotonin and dopamine neurotransmitter testing
has no correlation with the serotonin or dopamine
neurotransmitter phase
once the patient is taking
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa. |
|
For
patients not experiencing relief of symptoms on the
level 3 dosing after one week, a urinary
serotonin and dopamine neurotransmitter test should be ordered in order to
chart a future treatment course with the
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa
leading to relief of
symptoms with disease such as depression, ADHD, etc. |
|
Based
on the review of tens of thousands of urinary serotonin
and dopamine neurotransmitter
tests, it is a waste of time and money to attempt to
further regulate
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa dosing without obtaining a
urinary serotonin and dopamine neurotransmitter test once the patient has been
on level 3
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa dosing for one week with no relief
of symptoms. |
|
|
|
ADJUSTING
5-HTP aka 5HTP or 5 HTP,
tyrosine aka L-tyrosine AND L-dopa aka
dopa PROPERLY |
|
In adult patients being
treated for diseases
such as depression, ADHD, etc. other than obesity,
Restless Leg Syndrome, or Parkinsonism -
the recommendation is to increase the
5-HTP aka 5HTP or 5 HTP
and tyrosine aka L-tyrosine
dosing weekly until relief of
symptoms are obtained or until the level
3 dosing is in place - at which point,
if relief of symptoms have not been
obtain after one week, a urinary
serotonin and dopamine neurotransmitter test should be ordered.
It is not uncommon with the
inexperienced care giver that the
patient is left on level 1 or level 2
5-HTP aka 5HTP or 5 HTP
and tyrosine aka L-tyrosine dosing for prolonged periods
of time while relief of symptoms have
not been obtained. This approach makes
no sense, after the first week
additional time will not facilitate
relief of symptoms. The effects of and
response to
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa is like a light
switch. “It is on or off”. If relief of
symptoms is not obtained in one week (at
any given
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa dosing level),
additional time on that dosing level
will not lead to relief of symptoms.
The individual dosing needs of the
patient leading to relief of symptoms
needs to be established by properly
adjusting the
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa dosing in a
timely manner and ordering urinary
serotonin and dopamine neurotransmitter testing when indicated. In patients not receiving
relief of symptoms one week after the
level 3 dosing is prescribed, a urinary
serotonin and dopamine neurotransmitter test should be promptly
ordered. |
|
|
|
|
|
|
IN PATIENTS WHO HAVE
NOT EXPERIENCED RELIEF OF SYMPTOMS AFTER ONE WEEK ON A
GIVEN DOSING OF
5-HTP aka 5HTP or 5 HTP, tyrosine aka
L-tyrosine AND L-dopa aka dopa: |
|
Ø
Failure to increase
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa
dosing
to level 3 if needed is not optimal treatment
for depression, ADHD, etc. |
| Ø
Failure to order urinary serotonin and
dopamine neurotransmitter
testing when the patient has been on the level 3 dosing
for one week without relief of depression, ADHD, etc. symptoms is not optimal
treatment. |
|
The
difference between properly adjusting 5-HTP aka 5HTP or
5 HTP,
tyrosine aka L-tyrosine, and L-dopa aka dopa and ordering
urinary
serotonin and dopamine neurotransmitter testing and
simply starting patients with adjusting analogous to: |
|
“Treating patients properly and simply playing around
with 5-HTP aka 5HTP or 5 HTP, tyrosine aka L-tyrosine, and L-dopa
aka dopa.” |
| |
|
ONE
SIZE DOES NOT FIT ALL |
|
|
|
Care givers can
prescribe
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa for numerous
reasons. When the goal of treatment is
relief of symptoms, the patient should
be seen weekly and the
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa dosing
should be adjusted weekly until symptoms
of depression, ADHD, etc. are under control. If after 21 days of
treatment the patient still has not
received relief of symptoms of
depression, ADHD, etc. on level 3
dosing, urinary
serotonin and dopamine neurotransmitter testing should be
obtained in order to plot a proper
individualized course of
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa
dosing leading to relief of symptoms.
|
|
The problem with
attempts at
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa
therapy prior to
our research project is still a problem
with many of the “other approaches”
today. “Some patients get better, many
do not.” Optimal relief of symptoms in
patients requires proper
adjusting of the
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa dosing in a
timely manner and ordering urinary
serotonin and dopamine neurotransmitter testing when indicated. |
|
|
|
|
|
DOING IT RIGHT. |
|
DON’T LET YOUR PATIENTS SUFFER WITH SYMPTOMS. |
|
The
most common mistake we have seen with care givers treating
patients for depression, ADHD, etc. is to start
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa and
leave the patient on the same dose longer than one week
(in some cases, several weeks or months) when there is
no relief of symptoms at the end of one week.
Patients who do not receive relief of
symptoms after one week of
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa at a given dose
will not obtain relief of their symptoms by prolonging
the time that they stay at their current dosing level. |
|
It
takes 3 to 5 days for the maximum results of starting or
changing the
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa dosing to be seen. When the
patient returns to clinic after one week on a given
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa dosing, the question to ask IS NOT,
“How were your symptoms last week?” The question should
be, “How were you symptoms yesterday?” If the patient’s
symptoms were not under control for most of the previous
week, but were under control “yesterday” (the day before
the visit), you can leave the patient on the current
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa dosing and see the patient back in one week
to ensure symptoms are under control |
|
|
|
|
|
 |
| |
| |
| |
| |
| |
| 5HTP_4 |
 |
|
|
|
Group Dosing Needs |
|
|
|
|
|
BEYOND THE KEY HOLE |
|
In the past looking
5-HTP aka 5HTP or 5 HTP, tyrosine aka
L-tyrosine, and
L-dopa aka dopa was like looking at
the other side of a door through a key
hold. We see something there but results
when applied to group treatment were not
effective or consistent. In retrospect,
the problem was that we did not
understand the dosing ranges needed in
optimal group treatment for optimal
relief of symptoms. The individual
dosing needs of 5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine,
and L-dopa aka dopa to affect
relief of symptoms varies on a huge
level in group treatment. Unless you are
prepared to properly establish each
patient’s individual 5-HTP aka 5HTP or 5
HTP,
tyrosine aka L-tyrosine, and L-dopa aka
dopa dosing
as needed, you will not obtain optimal
results with your patients. |
|
|
|
5-HTP aka 5HTP or 5 HTP, tyrosine aka
L-tyrosine, and L-dopa aka dopa DOSING RANGES NEEDED |
|
FOR
OPTIMAL GROUP TREATMENT |
|
Individual
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa dosing needs vary on a huge scale.
The following are the dosing ranges for
individual
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa components that
are needed for optimal individual
results: |
|
Ø
5-HTP aka 5HTP or 5 HTP 37.5 to 3,000 mg per day |
|
Ø
tyrosine aka L-tyrosine 375 to 12,000 mg per day |
|
Ø
L-dopa aka dopa 120 to 12,000 mg per day. |
|
It is important that
5-HTP aka 5HTP or 5 HTP be used in proper balance with
the dopamine precursors. DO NOT use only
one 5-HTP aka 5HTP or 5 HTP, L-dopa aka
dopa, or
tyrosine aka L-tyrosine
you will deplete serotonin and dopamine neurotransmitter
levels. |
|
|
|
|
|
|
ESTABLISHING THE
INDIVIDUAL
5-HTP aka 5HTP or 5 HTP, tyrosine aka
L-tyrosine, and L-dopa aka dopa DOSING IN TREATMENT |
|
The goal of treatment is the optimal
relief of symptoms. In order to affect symptoms, each
patient needs to have the serotonin and catecholamine
precursors 5-HTP aka 5HTP or 5 HTP, tyrosine aka
L-tyrosine, and
L-dopa aka dopa established in an individualized
dosing level. The approach is: |
|
Ø
Start all patients on level 1 treatment
and see them back in one week. If symptoms are not under
control, adjust the 5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and
L-dopa aka dopa to levels 2 or 3, at
which point most patients will have found relief of
symptoms. |
|
Ø
If on level 3 the symptoms are not under
control obtain a urinary serotonin and dopamine neurotransmitter test and
follow the recommendations until symptoms resolve. |
|
Ø
Do not prescribe over 900 mg per day of
5-HTP aka 5HTP or 5 HTP or 5,000 mg per day of tyrosine
aka L-tyrosine without
urinary serotonin and dopamine neurotransmitter testing establishing the need to do so. |
|
|
|
MISSING THE BOAT ---
DO NOT USE ONLY 5-HTP aka 5HTP or 5 HTP |
|
|
|
Practicing medicine is
a serious responsibility. The goal is to
get diseases
such as depression, ADHD, etc.
and their symptoms under
control as soon as possible in all
patients. |
|
If you are not using
urinary serotonin and dopamine neurotransmitter testing when
indicated then you are not providing
optimal medical care and your patients
are not receiving optimal results. If
you are not using urinary serotonin and
dopamine neurotransmitter
testing, you are wandering in the dark
as you try and treat some of your
patients. |
|
THE
GOAL OF TREATMENT
is to optimize the outcomes of group treatment. Individual
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa
can be used to get some relief of
symptoms in some patients. From day one
of this project, we have used objective
observations with statistical analysis
to define conditions that facilitate
optimal group outcomes. The concept of
optimal group outcomes is at the heart
of our work. |
|
The following is inspired by a phone call from a physician
last week who said, “I have been using a
lot of plain 5-HTP aka 5HTP or 5 HTP (5-HTP
aka 5HTP or 5 HTP) lately.”
5-HTP aka 5HTP or 5 HTP when
used without dopamine precursors leads
to suboptimal group results in the
treatment of depression, AHDH, etc. It also
depletes dopamine in long-term
use. The real problem is the physician’s
lack of understanding on how to treat
patients with properly balanced
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa in order to achieve optimal
results. |
|
|
|
|
|
USE OF ONLY 5-HTP
aka 5HTP or 5 HTP OR
tyrosine aka L-tyrosine WILL NOT PROVIDE OPTIMAL GROUP RESULTS. |
|
Ø
5-HTP
aka 5HTP or 5 HTP needs to be given in proper balance with the dopamine
precursors tyrosine aka L-tyrosine (n-acetyl-tyrosine
aka L-tyrosine does not work)
and/or L-dopa aka dopa for optimal group results |
|
Ø
Long-term use of only 5-HTP aka 5HTP or 5 HTP depletes dopamine,
norepinephrine and epinephrine. |
|
Ø
Use of
only 5-HTP aka 5HTP or 5 HTP does nothing to address the problems caused
by or associated with dopamine dysfunction. |
|
Ø
Only
about 10% to 15% of patients achieve “good” results
using only 5-HTP aka 5HTP or 5 HTP. |
|
Ø
Group
treatment of disease such as depression, ADHD, etc. with only 5-HTP
aka 5HTP or 5 HTP is not nearly as effective as
using 5-HTP aka 5HTP or 5 HTP with dopamine precursors in proper balance
(in all diseases
such as depression, ADHD, etc.
which are caused by or associated with
serotonin and/or catecholamine dysfunction). |
|
|
|
|
|
 |
| |
| |
| |
| |
| |
| 5HTP_2 |
 |
| |
|
QUICK OVER VIEW OF TREATMENT |
| |
|
|
|
Urinary
Neurotransmitter Testing Pearls |
 |
At the first visit DO NOT
obtain urinary serotonin and
dopamine neurotransmitter
testing. Simply start the
patient on “level 1”
5-HTP aka 5HTP or
5 HTP,
tyrosine aka L-tyrosine, and
L-dopa aka dopa
dosing. |
 |
See the “level 1” patient back
in 1 week. If symptoms are not
under control, increase to
“level 2”
5-HTP aka 5HTP or
5 HTP,
tyrosine aka L-tyrosine, and
L-dopa aka dopa
dosing. |
 |
See the “level 2” patient back
in 1 week. If symptoms are not
under control, increase to
“level 3”
5-HTP aka 5HTP or
5 HTP,
tyrosine aka L-tyrosine, and
L-dopa aka dopa
dosing. |
|
| |
|
See the “level 3” patient back in 1
week. If symptoms are not under control,
obtain a urinary serotonin and dopamine neurotransmitter test
and follow the recommendations reported. |
|
|
|
|
|
|
|
|
 |
| |
| |
| |
| |
| |
| 5HTP 9 |
 |
| |
|
|
| |
|
|
|
|
|
|
Ø
The tyrosine aka L-tyrosine / 5-HTP aka
5HTP or 5 HTP /
L-dopa aka dopa series is only
recommended for the treatment of
obesity, restless leg syndrome, and
Parkinsonism. |
|
Ø
Start all other patients on the
5-HTP aka 5HTP or 5 HTP/tyrosine aka
L-tyrosine series. |
|
Ø
For patients who need urinary serotonin
and dopamine neurotransmitter lab testing,
testing will need to be ordered at the
correct time and properly utilized in
order to achieve relief of symptoms.
|
|
Ø
Testing prior to starting
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa
is
of no value if the goal is relief of
symptoms. |
|
|
Ø
Start all adult patients on the level 1
dosing. |
|
Ø
Orientate patients properly on what to
do if adverse reactions occur (such as
GI upset or first week problems). |
|
Ø
When the patient returns, the proper
question to ask is, “How were your
symptoms yesterday?” It takes 3 to 5
days for the full effects of starting or
changing dosing of
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa
dosing to be
seen. |
|
Ø
When the patient returns, the proper
question to ask is, “How were your
symptoms yesterday?” It takes 3 to 5
days for the full effects of starting or
changing
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa
dosing to be
seen. |
|
Ø
If symptoms are not under control in one
week, increase to the next dosing level
or obtain a laboratory test for
guidance. |
|
|
|
|
|
|
|
|
|
Protocols have been developed and refined over the last
9 years. Deviation from these protocols should not be
done unless a full understanding of
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa therapy
has been mastered. |
|
Patients need to be seen weekly and
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa need to
be adjusted accordingly until symptoms resolve. Failure
to do so will result in prolonged suffering and an
increase in treatment dropout rates. |
|
When
patients return for a visit one week after starting or
changing
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa dosing, the question to ask is
“How were your symptoms yesterday?” It takes 3 to 5 days
for the maximum response to occur. Therefore, the
response may not be observed until day 6 (the day before
the visit). |
|
In most
patients, complete relief of symptoms is like a light
switch - “it is either on or off”. Some patients require
several weeks of treatment during which symptoms are not
relieved. Then, after several weeks with no
improvements, they finally arrive at the
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa
dosing where the effects of the
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa turn on and
the symptoms turn off. |
|
|
|
If a patient is
experiencing problems with adverse reactions or is not
obtaining relief of symptoms, call NeuroResearch for a
free consult at 877-626-2220. |
|
|
|
|
|
 |
| |
| |
| |
| |
| |
| 5HTP 10 |
 |
|
|
|
THE APPROACH IS SIMPLE |
|
|
|
Adult
patients should be started on the level 1
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa
dosing and return to the clinic one week later. If
symptoms are not under control in one week, increase the
dose to the next level. If the patient still does not
have relief of symptoms after one week on the level 3
dosing, a urinary serotonin and dopamine neurotransmitter test should be
obtained. At the level 3 dosing level, 50% of patients
need more 5-HTP aka 5HTP or 5 HTP and 50% will need less 5-HTP
aka 5HTP or 5 HTP with more
dopamine precursors. While increasing the dose above
level 3 empirically will give relief to some patients,
the patients who do not need more than 900 mg per day of
5-HTP aka 5HTP or 5 HTP will not see results. Over half of the patients
who need urinary serotonin and dopamine testing find relief of symptoms with
only one urinary serotonin and dopamine neurotransmitter test. If you do not obtain
urinary serotonin and dopamine neurotransmitter testing when your patient gets no
relief on level 3 dosing those patients will not get
optimal group results. |
|
|
|
Use
of unbalanced
5-HTP aka 5HTP or 5 HTP, tyrosine aka
L-tyrosine, and L-dopa aka dopa
can deplete neurotransmitter
levels. |
|
|
|
|
|
 |
| |
| |
| |
| |
| |
| 5HTP 11 |
 |
|
|
|
OPTIMIZING PATIENT
CARE |
|
|
|
The goal of
treatment should be to help as many patients as possible
become symptom-free. Certainly, there are patients who
start
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa therapy and within one week are
symptoms-free. On the other end of the spectrum are
patients that need two to four months of weekly care
before their symptoms are under control. For these more
difficult patients, there are two keys for optimal
results: |
|
ü
Obtain
urinary serotonin and dopamine neurotransmitter tests when indicated.
|
|
ü
Obtain a
free telephone consult with the NeuroResearch doctors
when a patient isn’t getting better or when lab results
do not correlate with clinical observations. |
|
Labs should be ordered
once the adult patient has been on the neurotransmitter
dosing level 3
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa dosing for one week with no relief of symptoms.
While 80 to 85% of patients will find relief of their
symptoms without urinary serotonin and dopamine lab testing, the remaining patients
need their dosing adjusted with urinary serotonin and
dopamine laboratory guidance.
Without this dosing change, these patients will not find
relief of their symptoms. |
|
A consult is a very
powerful tool when treating a difficult patient. We will
do our best to correlate the laboratory results with
clinical observations in ordered to recommend an
5-HTP aka 5HTP or 5 HTP, tyrosine
aka L-tyrosine, and L-dopa aka dopa dosing. In some cases, the laboratory
serotonin and dopamine numbers take
on a whole new meaning once we are able to compare the
clinical history with the serotonin and dopamine lab results. There are indeed
serotonin and dopamine laboratory “gray areas,” which can best be addressed by
putting two heads together (the caregiver and the lab).
If your patient is not getting better, call for a
consult. |
|
|
|
|
|
 |
| |
| |
| |
| |
| |
| 5HTP 5 |
 |
| |
| THE NEED FOR
TRAINING |
| |
|
|
| |
| THE DOCS WHO DO
NOT OBTAIN PROPER TRAINING |
| |
|
|
| |
|
|
|
|
|
|
|
 |
| |
| |
| |
| |
| |
| 5HTP 7 |
 |
|
|
|
PROPER TREATMENT BASICS |
|
|
 |
|
|
|
|
|
|
 |
| |
| |
| |
| 5HTP 6 |
 |
|
|